Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 3 (2008), Issue 7 (July)

1. Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.
   J Gastroenterol, 43(5): 397-401. [Abstract] [Full-text]
2. Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease.
   J Infect Dis, 198(2): 218-25. [Abstract] [Full-text]
3. Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV.
   J Infect Dis, 198(2): 203-12. [Abstract] [Full-text]
4. Hepatitis C virus-induced secretion of inflammatory chemokines preferentially recruits NKG2A+CD8+ T cells.
   J Infect Dis, 198(2): 213-7. [Abstract] [Full-text]
5. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
   J Leukoc Biol, 84(1): 264-79. [Abstract] [Full-text]
6. Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.
   Expert Rev Mol Diagn, 8(4): 369-77. [Abstract] [Full-text]
7. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
   J Infect, 57(1): 72-7. [Abstract] [Full-text]
8. Aggravation of viral hepatitis by platelet-derived serotonin.
   Nat Med, 14(7): 756-61. [Abstract] [Full-text]
9. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
   Gastroenterology, 135(1): 111-21. [Abstract] [Full-text]
10. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.
    Gastroenterology, 135(1): 100-10. [Abstract] [Full-text]
11. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
    Gastroenterology, 135(1): 226-33. [Abstract] [Full-text]
12. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
    Brain Behav Immun, 22(6): 870-80. [Abstract] [Full-text]
13. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma.
    Eur J Haematol, 81(1): 51-7. [Abstract] [Full-text]
14. Severe thrombocytopenia associated with acute hepatitis E virus infection.
    J Clin Microbiol, 46(7): 2450-2. [Abstract] [Full-text]
15. Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia.
    J Clin Microbiol, 46(7): 2160-6. [Abstract] [Full-text]
16. Management of hepatitis B virus.
    J Antimicrob Chemother, 62(2): 224-8. [Abstract] [Full-text]
17. Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes.
    J Virol, 82(15): 7524-32. [Abstract] [Full-text]
18. Differences in hepatitis C virus (HCV)-specific CD8 T-cell phenotype during pegylated alpha interferon and ribavirin treatment are related to response to antiviral therapy in patients chronically infected with HCV.
    J Virol, 82(15): 7567-77. [Abstract] [Full-text]
19. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Gut, 57(8): 1121-8. [Abstract] [Full-text]
20. Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore.
    J Pharmacol Exp Ther, 326(2): 657-71. [Abstract] [Full-text]
21. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
    Arch Surg, 143(7): 679-85; discussion 685. [Abstract] [Full-text]
22. Acute hepatitis C.
    Lancet, 372(9635): 321-32. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.